Acute Coronary Syndrome News and Research

RSS

Intensive blood-pressure control benefits older hypertensive patients

Aggressive blood pressure treatment in older hypertensive patients lowers the incidence of cardiovascular events compared to standard therapy, without increasing adverse outcomes. That's the finding of late breaking research presented in a Hot Line session today at ESC Congress 2021.

30 Aug 2021

Smoking cessation more likely to improve mood in heart attack survivors

Smokers with depression at the time of a heart attack who quit smoking are more likely to improve their mood than those who continue the habit. That's the finding of research presented at ESC Congress 2021.

27 Aug 2021

Improving lifestyle and medication use could add healthy years of life after a heart attack

Adherence to lifestyle advice and medications could add seven healthy years of life after a heart attack, according to a study presented at ESC Congress 2021.

26 Aug 2021

New AHA Presidential Advisory addresses opioid use and its effects on heart and brain health

The misuse of opioids in the United States continues to lead to high rates of dependency as well as a staggering number of deaths due to overdose.

19 Aug 2021

High-deductible health plans associated with decreased ED visits for chest pain

Up to 7 million people each year receive care in an emergency department (ED) for chest pain, a symptom of a potential heart condition. Over 80 percent of chest pain patients, however, ultimately have no evidence of cardiovascular disease or acute coronary syndrome.

28 Jun 2021

New research identifies a link between the gut microbiome and strokes

A recent study demonstrates the impact of diets that are high in choline and trimethylamine on increasing stroke severity and functional deficits.

21 Jun 2021

Landmark study confirms that controlled blood pressure is key to prevent stroke, heart disease

Follow-up data from the landmark SPRINT study of the effect of high blood pressure on cardiovascular disease have confirmed that aggressive blood pressure management -- lowering systolic blood pressure to less than 120 mm Hg -- dramatically reduces the risk of heart disease, stroke, and death from these diseases, as well as death from all causes, compared to lowering systolic blood pressure to less than 140 mm Hg.

22 May 2021

Randomized clinical trials compare effects of coronary revascularization versus medical therapy alone

A rigorous meta-analysis of randomized clinical trials (RCTs) that compared the effects of medical therapies alone with medical therapies plus revascularization in patients with stable ischemic heart disease (SIHD) was presented at EuroPCR on May 18, 2021.

19 May 2021

New app enables faster treatment of patients suffering a heart attack

Patients suffering a heart attack received percutaneous coronary intervention (PCI), a procedure to clear blocked arteries in the heart, an average of 10 minutes faster after clinicians and paramedics began using an app to facilitate efficient hospital intakes for these patients, according to a study being presented at the American College of Cardiology's 70th Annual Scientific Session.

5 May 2021

Statins shown to reduce COVID-19 severity and lower mortality

Much attention has been focused on ways to reduce the deadly exaggeration of normal inflammatory reactions to this pathogen. A new research paper posted to the medRxiv* preprint server describes the alleviation of hyper-inflammatory phenomena following the administration of statins, drugs more widely known for their use in reducing blood cholesterol levels, to patients with COVID-19.

11 Feb 2021

Neuromuscular training in cardiac rehabilitation improves quality of life in heart attack patients

Neuromuscular training improves balance, stability, coordination and reaction speed, increasing patients’ ability to perform daily chores and allowing them to gain quality of life.

5 Feb 2021

Study finds treatment disparities for men and women with chest pain

The use of a standardized tool for assessing the risk of serious outcomes in patients with chest pain was associated with women at high risk receiving comparable care to men, according to new research published in the Annals of Emergency Medicine.

23 Dec 2020

COVID-19 guidance in Sweden could have reduced people's risks of heart attack, indicates study

A new study suggests that COVID-19 guidance in Sweden may have reduced people's risks of having a heart attack.

4 Dec 2020

Body mass index and severe COVID-19

French researchers led by first author Abdallah Al-Salameh from the Department of Endocrinology, Diabetes Mellitus and Nutrition, Amiens University Hospital, Amiens, France, have published findings of their study titled, “The association between body mass index class and coronavirus disease 2019 outcomes,” in the latest issue of the International Journal of Obesity.

26 Nov 2020

International trialists receive prestigious award for research on low-dose aspirin

The international trialists Professors Lars Wallentin, Jan van Gijn, Bo Norrving and Tom Meade were recognized for their work on low-dose aspirin, with the presentation of the International Aspirin Foundation Senior Science Award.

22 Nov 2020

Potent antiplatelet drug not superior to standard of care in reducing heart attack risk during angioplasty

The use of the more potent antiplatelet medication ticagrelor was not superior to clopidogrel in the reduction of the rate of heart attack or severe complications among people undergoing an elective procedure to open a blocked artery, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

16 Nov 2020

Research uncovers a new underlying cause of heart attack

Heart attacks strike suddenly and have a range of different triggers. Researchers from Charité - Universitätsmedizin Berlin and the German Centre for Cardiovascular Research (DZHK) were able to uncover a further underlying cause.

10 Nov 2020

Patients with newly diagnosed atrial fibrillation benefit from early rhythm control therapy

Patients with newly diagnosed atrial fibrillation benefit from early rhythm control therapy, according to results of the EAST-AFNET 4 trial presented in a Hot Line session today at ESC Congress 2020.

31 Aug 2020

ESC publishes treatment guidelines for non-ST-segment elevation acute coronary syndrome

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation